Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis
Mehmet Kanbay, Laura Țăpoi, Carina Ureche, Cem Tanrıöver, Enes Çevik, Atalay Demiray, Barış Afşar, David Z.I. Cherney, Adrian Covic
Topics & Concepts
MedicineHematocritInternal medicinePlaceboCanagliflozinType 2 diabetesHemoglobinMeta-analysisDiabetes mellitusDapagliflozinRandomized controlled trialGastroenterologyKidney diseaseEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementErythropoietin and Anemia TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins